Causes and Prevalence of Visual Impairment among Adults in the United States

Archives of Ophthalmology

Volumn 122, Issue 4, 2004, Pages 477-485

  Congdon, Nathan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AGING; ARTICLE; AUSTRALIA; CATARACT; ETHNOLOGY; EUROPE; FEMALE; GENDER; GLAUCOMA; HISPANIC; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; RACE; RETINA MACULA AGE RELATED DEGENERATION; UNITED STATES; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRALIA; BLINDNESS; CATARACT; CAUSALITY; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLAUCOMA; HISPANIC AMERICANS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES; VISION, LOW; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 1842530296     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.4.477     Document Type: Article

References (38)

1. Jette AM, Branch LG. Impairment and disability in the aged. J Chronic Dis. 1985;38:59-65.
2. LaForge RG, Spector WD, Sternberg J. The relationship of vision and hearing-impairment to one-year mortality and functional decline. J Aging Health. 1992;4:126-148.
3. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. Invest Ophthalmol Vis Sci. 1997;38:72-82.
4. Lee DJ, Gomez-Marin O, Lam BL. Prevalence of uncorrected binocular distance visual acuity in Hispanic and non-Hispanic adults: results from the HHANES and the NHANES I. Ophthalmology. 1998;105:552-560.
5. Krueger DE, Ederer F. Visual Acuity Impairment Survey Pilot Study. Office of Biometry and Epidemiology, National Eye Institute, National Institutes of Health, Public Health Service, Dept of Health and Human Services; January 1984. National Technical Information Service publication PB84 1567173.
6. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98:1310-1315.
7. Rahmani B, Tielsch JM, Katz J, Gottsch J, Quigley H, Javitt J, Sommer A. The cause-specific prevalence of visual impairment in an urban population: the Baltimore Eye Survey. Ophthalmology. 1996;103:1721-1726.
8. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825.
9. Rodriguez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of US Hispanics. Ophthalmology. 2002;109:737-743.
10. US Census 2000 Population Tables. US Census 2000 Summary File 1 (SF 1) 100-Percent Data. Available at: http://factfinder.census.gov/servlet/DatasetMainPageServlet?_lang=en. Accessed December 9, 2002.
11. Moser CL, Martin-Baranera M, Vega F, Draper V, Gutierrez J, Mas J. Survey of blindness and visual impairment in Bioko, Equatorial Guinea. Br J Ophthalmol. 2002;86:257-260.
12. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology. 2001;108:1751-1756.
13. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol. 2001;8:39-56.
14. Evans JR, Fletcher AE, Wormald RP, et al. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol. 2002;86:795-800.
15. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl): 335-610.
16. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653-658.
17. Van Newkirk MR, Weih L, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology. 2001;108:960-967.
18. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103:357-364.
19. Lam BL, Lee DJ, Gomez-Marin O. Prevalence of usual-corrected binocular distance visual acuity impairment in Hispanic and non-Hispanic adults. Ophthalmic Epidemiol. 2000;7:73-83.
20. van der Pols JC, Bates CJ, McGraw PV, et al. Visual acuity measurements in a national sample of British elderly people. Br J Ophthalmol. 2000;84:165-170.
21. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology. 1999;106:1049-1055.
22. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106:1056-1065.
23. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
24. The AGIS Investigators. The Advanced Glaucoma Intervention Study, 6: effect of cataract on visual field and visual acuity. Arch Ophthalmol. 2000;118:1639-1652.
25. Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of Medicare. Arch Ophthalmol. 2000;118:253-256.
26. Harris EL, Sherman SH, Georgopoulos A. Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care. 1999;22:779-783.
27. Arfken CL, Reno PL, Santiago JV, Klein R. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diabetes Care. 1998;21:792-795.
28. Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002;288:475-482.
29. Escarce JJ. Would eliminating differences in physician practice style reduce geographic variations in cataract surgery rates? Med Care. 1993;31:1106-1118.
30. Goldzweig CL, Mittman BS, Carter GM, et al. Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings. JAMA. 1997;277:1765-1768.
31. McCarty CA, Nanjan MB, Taylor HR. Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci. 2000;41:3720-3725.
32. Age-Related Eye Diseases Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
33. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology. 1995;102:647-661.
34. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology. 1978;85:82-106.
35. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796-1806.
36. Munoz B, West SK, Rodriguez J, et al. Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002;43:608-614.
37. Writing Group for the Eye Diseases Prevalence Research Group. The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol. 2004;122:495-505.
38. Massof RW. A model of the prevalence and incidence of low vision and blindness among adults in the United States. Optom Vis Sci. 2002;79:31-38.